Humana Inc (NYSE:HUM) fall -9.58% during last trading as the stock added -$17.24 to finish the day at $162.74 with about 9.07M shares changing hands, compared to its three month average trading volume of 1.48M. The $ 24.63B market cap company, which fluctuated between $158.60 and $180.37 during the day, currently situated 5.17% above its 52 week low of $154.74 and -14.95% away from its one year high of $191.34. The RSI of 32.53 indicates the stock is overbought at the current levels, sell for now.
Humana Inc. is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Galena Biopharma Inc (NASDAQ:GALE) fall -$0.074 to close the day at a new closing price of $0.515, a -12.59% decrease in value from its previous closing price that moved the stock 83.79% above its 52 week low of $0.28. A total of 9.16M shares exchanged hands during the day compared with its three month average trading volume of 11.22M. The stock, which fluctuated between $0.51 and $0.58 during the day, currently situated -79.33% below its 52 week high. The stock is down by -74.52% in the past one month and down by -64.51% over the past three months. With a one year target estimate of $3.13 and RSI of 26.07, the stock still has upside potential, making it a hold for now.
Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company’s development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company’s NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies.
Spirit Realty Capital, Inc (New) (NYSE:SRC) had a light trading with around 9.25M shares changing hands compared to its three month average trading volume of 3.95M. The stock traded between $12.72 and $13.03 before closing at the price of $12.96 with -0.77% change on the day. The company is currently trading 55.82% above its 52 week low of $8.32 and -1.29% above its 52 week high of $13.13. Both the RSI indicator and target price of 75.43 and $12.23 respectively, lead us to believe that it could drop over the coming weeks.
Spirit Realty Capital, Inc is a publicly traded real estate investment trust. The firm primarily acquires across the United States single tenant operationally essential real estate, which refers to generally free-standing, commercial real estate facilities where tenants conduct retail, service or distribution activities that are essential to the generation of their sales and profits. The firm was formerly known as Spirit Finance Corp. Spirit Realty Capital, Inc was formed on August 14, 2003 and is domiciled in the United States.